Tocilizumab doesn't ease symptoms or prevent death in COVID-19 inpatients: NEJM Dr. Kamal Kant Kohli26 Oct 2020 4:09 PM ISTBOSTON - The drug tocilizumab (Actemra) does not reduce the need for breathing assistance with mechanical ventilation or prevent death in moderately...
New Ultrasound technique may precisely assess pulmonary fibrosis and pulmonary edema Medical Dialogues Bureau26 Oct 2020 8:53 AM ISTResearchers from North Carolina State University and the University of North Carolina have developed a technique that uses ultrasound to provide...
Cannabis dependence tied to poor outcomes in Asthma Exacerbations: CHEST Dr. Nandita Mohan26 Oct 2020 8:33 AM ISTResearchers have found in a new study that patients of cannabis dependence have worse outcomes in Asthma exacerbations.The research was presented at...
Tocilizumab holds little potential for treatment of COVID 19 patients with pneumonia: JAMA Medha Baranwal24 Oct 2020 5:15 AM ISTDelhi: Three JAMA studies have shed light on the use of the immunosuppressive drug tocilizumab for COVID-19 patients with pneumonia. One of them...
Shorter TB treatment regimen as effective as longer course: CDC Study Medha Baranwal23 Oct 2020 7:13 PM ISTUSA: A four-month daily treatment containing high-dose rifapentine with moxifloxacin is as effective as the currently recommended six-month daily...
Spectral CT improves detection of early-stage COVID-19 Medical Dialogues Bureau22 Oct 2020 9:20 PM ISTChest CT has been used on a massive scale to help identify and evaluate suspected or confirmed COVID-19 cases, especially when RT-PCR testing was not...
CPAP treatment improves outcomes in patients undergoing cardiac surgery: CHEST Medha Baranwal22 Oct 2020 6:14 PM ISTUSA: Routine CPAP in obstructive sleep apnea (OSA) patients undergoing surgical aortic valve replacement (AVR) helps in shorter hospital...
Steroid use in asthma linked to heightened risk of brittle bones and fractures Hina Zahid22 Oct 2020 11:01 AM ISTTaking steroid inhalers or tablets to treat asthma or control flare-ups is linked to a heightened risk of brittle bones (osteoporosis) and increased...
Cipla launches generic Idiopathic Pulmonary Fibrosis drug Nintedanib in India Ruchika Sharma21 Oct 2020 1:00 PM ISTNew Delhi: Pharma major Cipla on Tuesday said it has launched generic Nintedanib used for the treatment of Idiopathic Pulmonary Fibrosis (IPF) under...
Double Therapy promising treatment of Tuberculosis with C. Difficile, finds study Dr Satabdi Saha20 Oct 2020 7:09 PM ISTPatients with tuberculosis and suffering from C. difficile infections (CDI) concurrently,are a major challenge to physicians. Clostridiun ...
BDR Pharma unveils idiopathic pulmonary fibrosis drug Nintedanib in India Ruchika Sharma20 Oct 2020 11:06 AM ISTIPF is lung disorder where there is scarring of the lungs due to an unknown cause, BDR Pharmaceuticals said in a statement.
CBD increases level of protective peptide and reduces lung damage from COVID-19 Hina Zahid20 Oct 2020 6:15 AM ISTOne way CBD appears to reduce the "cytokine storm" that damages the lungs and kills many patients with COVID-19 is by enabling an increase in levels...
